RI
GLUE icon

RTW Investments’s Monte Rosa Therapeutics GLUE Stock Holding History

RTW Investments’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,214,572
Closed -$9.24M – 64
2022
Q4 		$9.24M Hold
1,214,572
– – 0.19% 49
2022
Q3 		$9.92M Hold
1,214,572
– – 0.23% 54
2022
Q2 		$11.7M Hold
1,214,572
– – 0.3% 52
2022
Q1 		$17M Hold
1,214,572
– – 0.35% 56
2021
Q4 		$24.8M Hold
1,214,572
– – 0.36% 62
2021
Q3 		$26M Hold
1,214,572
– – 0.39% 54
2021
Q2 		$25.2M Buy
+1,214,572
New +$24.7M 0.38% 54

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments's GLUE Position: Q1 2023 in Review

RTW Investments sold out of Monte Rosa Therapeutics (GLUE) in Q1 2023, closing a stake of 1,214,572 shares — an estimated $9.24M sold.

RTW Investments first reported a position in GLUE in Q2 2021 and held it in 7 quarters. The position peaked at $26M in Q3 2021. 69 funds tracked by Wall St. Rank hold GLUE as of Q1 2023.

  • RTW Investments reported no remaining Monte Rosa Therapeutics position as of Q1 2023 after selling out during the quarter.
  • RTW Investments sold 1,214,572 Monte Rosa Therapeutics shares in Q1 2023, an estimated $9.24M.
  • RTW Investments first reported a position in Monte Rosa Therapeutics in Q2 2021 and held it in 7 quarters.
  • RTW Investments's Monte Rosa Therapeutics position peaked at $26M in Q3 2021.
  • 69 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.